Search results
Novo Nordisk dethrones Tesla on Obesity Pill Hope. Time to Invest?
FX Empire via Yahoo Finance· 3 months agoIts market cap surpassed a staggering $604 billion, eclipsing the highly popular electric vehicle...
Novo Nordisk (NVO) Raises Sales Outlook for 2023, Shares Gain
Zacks via Yahoo Finance· 8 months agoNovo Nordisk NVO upped its sales and operating profit forecast for 2023 yet again on the back of...
Altimmune (ALT) Rises 7% on Completing Dosing in Obesity Study
Zacks via Yahoo Finance· 9 months agoAltimmune (ALT) completes the dosing of all patients in the mid-stage obesity study of pemvidutide....
Novo Nordisk (NVO) Increases Sales & Operating Profit Guidance
Zacks via Yahoo Finance· 1 year agoNovo Nordisk NVO announced sales and operating profit for the first quarter of 2023 and increased...
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 10 months agoNovo Nordisk's (NVO) Diabetes and Obesity Care products are expected to have boosted sales in the...
Eli Lilly (LLY) Q2 Earnings Beat, Mounjaro Powers Sales Growth
Zacks via Yahoo Finance· 10 months agoEli Lilly and Company LLY reported second-quarter 2023 adjusted earnings per share of $2.11, which...
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates
Zacks via Yahoo Finance· 2 years agoNovo Nordisk A/S NVO reported third-quarter 2022 earnings of 86 cents per American Depositary...
Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up
Zacks via Yahoo Finance· 2 months agoBiophytis (BPTS) rises in the after-market hours as it announces the launch of a new clinical...
Lilly's (LLY) Eczema Candidate Lebrikizumab Faces FDA Rejection
Zacks via Yahoo Finance· 8 months agoEli Lilly and Company LLY announced that the FDA has issued a complete response letter (CRL) to its...
3 Large Drug Stocks That Have Outperformed Industry YTD
Zacks via Yahoo Finance· 7 months agoThe performance of the drug and biotech sector has been lackluster this year, especially in the...